FORM 3
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or
Section 30(f) of the Investment Company Act of 1940
_______________________________________________________________________________
1. Name and Address of Reporting Person
Kanzer, Steve
- -----------------------------------------------------
(Last) (First) (Middle)
375 Park Avenue
- -----------------------------------------------------
(Street)
- -----------------------------------------------------
(City) (State) (Zip)
_______________________________________________________________________________
2. Date of Event Requiring Statement (Month/Day/Year)
6/14/96
_______________________________________________________________________________
3. IRS or Social Security Number of Reporting Person (Voluntary)
XXX-XX-XXXX
_______________________________________________________________________________
4. Issuer Name and Ticker of Trading Symbol
ImmunoTherapeutics, Inc.
_______________________________________________________________________________
5. Relationship of Reporting Person to Issuer
(Check all applicable)
[ ] 10% Owner
[x] Director
[ ] Officer (give title below)
[ ] Other (specify below)
--------------------------------------------------
--------------------------------------------------
_______________________________________________________________________________
6. If Amendment, Date of Original (Month/Year)
_______________________________________________________________________________
Page 1
<PAGE>
FORM 3 (continued)
<TABLE>
<CAPTION>
TABLE I--Non-Derivative Securities Beneficially Owned
- ----------------------------------------------------------------------------
1. 2. 3. 4.
- --------------------- -------- ---------- ----------------------
Title of Amount of Ownership Nature of Indirect
Security Securities Form:Direct Beneficial
(Instr. 4) Beneficially (D) or Ownership
Owned Indirect (Instr. 4)
(Instr. 4) (I)(Instr. 5)
- --------------------- -------- ---------- ----------------------
<S> <C> <C> <C>
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly. (Print or Type Responses)
Page 2
<PAGE>
FORM 3 (continued)
<TABLE>
<CAPTION>
TABLE II--Derivative Securities Beneficially Owned
(e.g. puts, calls, warrants, options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------------
1. 2. 3. 4. 5. 6.
- ---------- -------------- -------------- -------- --------- ---------
Title and Ownership
Date Exer- Amount of Form of
cisable and Underlying Deriv-
Expiration Securities ative
Date (Month/ (Instr. 3 Conver Security:
Day/Year) and 4) sion or Direct
-------------- -------------- Exercise (D) or Nature of
Title of Date Amount Price of Indirect Indirect
Derivative Exer- Expir- or Num- Deri- (I) Beneficial
Security cis- ation ber of vative (Instr. Ownership
(Instr. 4) able Date Title Shares Security 5) (Instr. 5)
- ---------- ------- ----- ----- ------ -------- --------- ---------
<S> <C> <C> <C> <C> <C> <C> <C>
Options to 6/12/96 6/12/206 Common 200,000 $.20 D
acquire Stock,
200,000 par value
shares or $.001 per
Common Stock, share
par value
$.001 per
share
</TABLE>
Explanation of Responses:
- -----------------------------------------------------
- -----------------------------------------------------
/s/ Steve Kanzer 6/21/96
---------------------------------------- --------------------
** Signature of Reporting Person Date
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
Page 3
